More info:

• Popular Products

  Viagra Cialis Viagra Professional Cialis Professional Amoxil Prednisolone Lasix Propecia Levitra

• Brafix Cranial Orthosis: Evidence-Based Correction for Positional Plagiocephaly

  Product Description: Brafix is a Class IIa medical device, specifically a non-invasive cranial remolding orthosis, designed for the management of positional plagiocephaly, brachycephaly, and scaphocephaly in infants. It functions through the application of gentle, persistent pressure to guide cranial growth during a period of rapid development, promoting symmetrical skull formation. Its use is indicated when conservative repositioning therapy has proven insufficient, typically for infants aged 3 to 18 months with moderate to severe cranial deformation.

• Asendin

  Product Description: Asendin is a prescription medical device, specifically a non-invasive transcranial electrostimulation (TES) system, designed for the adjunctive treatment of major depressive disorder (MDD) in adult patients who have had an inadequate response to initial antidepressant pharmacotherapy. It delivers a proprietary, low-intensity, alternating current waveform via a headset to modulate cortical activity. Think of it not as a pill, but as a targeted neuromodulation tool—a digital therapeutic that aims to recalibrate dysregulated neural circuits implicated in depression.

• Deflazacort: A Glucocorticoid for Inflammatory and Autoimmune Conditions - Evidence-Based Review

  Product Description Deflazacort is a synthetic glucocorticoid, a corticosteroid medication, prescribed for its potent anti-inflammatory and immunosuppressive effects. It is structurally related to prednisolone but differs by the presence of an oxazoline ring. This monograph details its pharmacology, therapeutic applications, safety profile, and evidence base, intended for healthcare professionals and informed patients. It is available in tablet form, typically at strengths of 6 mg, 18 mg, and 30 mg, and is not an over-the-counter dietary supplement but a prescription pharmaceutical agent.

• Synthroid: Precise Hormone Replacement for Hypothyroidism - Evidence-Based Review

  Let’s begin with a detailed description of the product itself, before we get into the formal structure. Synthroid is the brand name for levothyroxine sodium, a synthetic form of the thyroid hormone thyroxine (T4). It’s not a dietary supplement or a device in the traditional sense; it’s a prescription medication, a hormone replacement therapy, and it’s one of the most prescribed drugs in the world. Its role is singular and critical: to replace or supplement thyroid hormone in patients whose thyroid gland is underactive or absent.

• Hair Loss Cream

  Hair Loss Cream: A Topical Multi-Target Approach for Androgenetic Alopecia - Evidence-Based Review Let’s talk about a product that, frankly, I was deeply skeptical about when it first crossed my desk. Another “miracle cream” for hair loss, I thought. But as I dug into the formulation and the preliminary data, and later, as I started using it in my practice with a specific subset of patients, my perspective shifted. This isn’t a single-agent solution; it’s a concerted, multi-target topical approach designed to address the pathophysiology of androgenetic alopecia (AGA) at several points.

• Clopidogrel

  Clopidogrel è, senza dubbio, uno dei cardini della terapia antitrombotica moderna. Appartiene alla classe degli inibitori del recettore P2Y12 dell’adenosina difosfato (ADP) ed è classificato come un profarmaco. In termini pratici, significa che viene somministrato in una forma inattiva e richiede una trasformazione metabolica nel fegato per diventare il composto attivo che inibisce in modo irreversibile l’aggregazione piastrinica. La sua introduzione ha rappresentato un passo avanti significativo rispetto all’aspirina, offrendo un meccanismo d’azione complementare e sinergico.

• Daliresp: Riduzione del Rischio di Riacutizzazioni nella BPCO Severa - Monografia Evidenze-Based

  Product Description Daliresp, con il principio attivo roflumilast, è un farmaco antinfiammatorio orale di classe PDE4 inibitore, approvato dall’EMA e dall’AIFA. È indicato come trattamento di mantenimento per ridurre il rischio di riacutizzazioni (esacerbazioni) in pazienti adulti con Broncopneumopatia Cronica Ostruttiva (BPCO) di gravità severa (FEV1 post-broncodilatatore <50% del predetto) associata a bronchite cronica, e con una storia di riacutizzazioni frequenti, in aggiunta alla terapia broncodilatatrice di fondo. Non è un broncodilatatore e non deve essere utilizzato per il sollievo sintomatico acuto del broncospasmo.

• Naltrexone

  Let’s talk about naltrexone. It’s one of those tools in the pharmacopeia that, over my twenty-odd years in clinical practice, has evolved from a very niche, specific agent into something with surprisingly broad—and sometimes controversial—applications. If you’d asked me about it in the late 90s, I’d have said it’s for opioid and alcohol dependence, full stop. End of story. But medicine, as we know, is rarely that simple. The journey of naltrexone from a straightforward blocker to a nuanced modulator is a fascinating case study in drug repurposing and the sometimes serendipitous nature of clinical observation.

• Metoclopramide

  Metoclopramide is a potent prokinetic and antiemetic agent used for gastroparesis, nausea, and vomiting. This comprehensive monograph details its mechanism of action, clinical indications, dosing, and critical safety profile, including the black box warning for tardive dyskinesia. Learn about the evidence-based applications and essential monitoring guidelines for safe use in clinical practice. Let’s talk about metoclopramide. It’s one of those drugs that sits in your toolkit, incredibly effective when used correctly, but with a side effect profile that demands respect—the kind of drug where you really need to know the patient, the history, and have a clear exit strategy.